Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

3518 ARTÍCULOS , VIENDO DEL 1291 AL 1305

A Framework for Developing Pharmacotherapy for Agitation in Alzheimer's Disease: Recommendations of the ISCTM* Working Group

O'Gorman C, Khoury R, Anderson A, Carter M, DiCesare F, Dubé S, Ereshefsky L, Grossberg G, Hefting N, Khan S, Lind S, Moebius H, Shiovitz T, Rosenberg P.

J Prev Alzheimers Dis. 2020;7(4):274-282. doi: 10.14283/jpad.2020.37.

Factors Associated with Lumbar Puncture Participation in Alzheimer's Disease Research

Blazel MM, Lazar KK, Van Hulle CA, Ma Y, Cole A, Spalitta A, Davenport-Sis N, Bendlin BB, Wahoske M, Illingworth C, Gleason CE, Edwards DF, Blazel H, Asthana S, Johnson SC, Carlsson CM.

J Alzheimers Dis. 2020;77(4):1559-1567. doi: 10.3233/JAD-200394.

Protein Biomarkers for the Diagnosis of Alzheimer's Disease at Different Stages of Neurodegeneration

Pérez M, Hernández F, Avila J.

Int J Mol Sci. 2020 Sep 15;21(18):6749. doi: 10.3390/ijms21186749.

Cerebrovascular pathology in Alzheimer's disease: Hopes and gaps

Badji A, Westman E.

Psychiatry Res Neuroimaging. 2020 Dec 30;306:111184. doi: 10.1016/j.pscychresns.2020.111184. Epub 2020 Sep 7.

Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease

Gustavsson A, Pemberton-Ross P, Gomez Montero M, Hashim M, Thompson R.

Expert Rev Pharmacoecon Outcomes Res. 2020 Dec;20(6):563-570. doi: 10.1080/14737167.2020.1822738. Epub 2020 Sep 20.

Exploring the Role of Aggregated Proteomes in the Pathogenesis of Alzheimer's Disease

Narayanan SE, Sekhar N, Rajamma RG, Marathakam A, Al Mamun A, Uddin MS, Mathew B.

Curr Protein Pept Sci. 2020;21(12):1164-1173. doi: 10.2174/1389203721666200921152246.

Cortisol hypersecretion and the risk of Alzheimer's disease: A systematic review and meta-analysis

Zheng B, Tal R, Yang Z, Middleton L, Udeh-Momoh C.

Ageing Res Rev. 2020 Dec;64:101171. doi: 10.1016/j.arr.2020.101171. Epub 2020 Sep 22.

Neprilysin expression and functions in development, ageing and disease

Nalivaeva NN, Zhuravin IA, Turner AJ.

Mech Ageing Dev. 2020 Dec;192:111363. doi: 10.1016/j.mad.2020.111363. Epub 2020 Sep 26.

Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline

Pettigrew C, Soldan A, Wang J, Wang MC, Arthur K, Moghekar A, Gottesman RF, Albert M.

Neurology. 2020 Dec 8;95(23):e3093-e3103. doi: 10.1212/WNL.0000000000010946. Epub 2020 Sep 28.

Alzheimer disease biomarker profiles in dementia with Lewy bodies: Does A plus T spell D-L-B?

Koyama AK, Irwin DJ.

Neurology. 2020 Dec 15;95(24):1076-1077. doi: 10.1212/WNL.0000000000010958. Epub 2020 Sep 28.

Association of Cigarette Smoking With Cerebrospinal Fluid Biomarkers of Neurodegeneration, Neuroinflammation, and Oxidation

Liu Y, Li H, Wang J, Xue Q, Yang X, Kang Y, Li M, Xu J, Li G, Li C, Chang HC, Su KP, Wang F.

JAMA Netw Open. 2020 Oct 1;3(10):e2018777. doi: 10.1001/jamanetworkopen.2020.18777.

Cerebrospinal fluid A beta 1-40 peptides increase in Alzheimer's disease and are highly correlated with phospho-tau in control individuals

Lehmann S, Dumurgier J, Ayrignac X, Marelli C, Alcolea D, Ormaechea JF, Thouvenot E, Delaby C, Hirtz C, Vialaret J, Ginestet N, Bouaziz-Amar E, Laplanche JL, Labauge P, Paquet C, Lleo A, Gabelle A; Alzheimer’s Disease Neuroimaging Initiative (ADNI).

Alzheimers Res Ther. 2020 Oct 2;12(1):123. doi: 10.1186/s13195-020-00696-1.

Retinal biomarkers for Alzheimer's disease and vascular cognitive impairment and dementia (VCID): implication for early diagnosis and prognosis

Czakó C, Kovács T, Ungvari Z, Csiszar A, Yabluchanskiy A, Conley S, Csipo T, Lipecz A, Horváth H, Sándor GL, István L, Logan T, Nagy ZZ, Kovács I.

Geroscience. 2020 Dec;42(6):1499-1525. doi: 10.1007/s11357-020-00252-7. Epub 2020 Oct 4.

Sleep-disordered breathing and the risk of Alzheimer's disease

Liguori C, Maestri M, Spanetta M, Placidi F, Bonanni E, Mercuri NB, Guarnieri B.

Sleep Med Rev. 2021 Feb;55:101375. doi: 10.1016/j.smrv.2020.101375. Epub 2020 Sep 6.

The Dual Role of Glutamatergic Neurotransmission in Alzheimer's Disease: From Pathophysiology to Pharmacotherapy

Bukke VN, Archana M, Villani R, Romano AD, Wawrzyniak A, Balawender K, Orkisz S, Beggiato S, Serviddio G, Cassano T.

Int J Mol Sci. 2020 Oct 9;21(20):7452. doi: 10.3390/ijms21207452.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias